趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體
Polyclonal Antibody to Chemokine (C-X-C motif) ligand 7 ( CXCL7)
CXCL7; PPBP; PBP; B-TG1; CTAP-III; CTAP3; CTAPIII; LA-PF4; LDGF; MDGF; NAP2; SCYB7; TC1; TC2; TGB1; THBGB1; Pro-Platelet Basic Protein; Beta-Thromboglobulin
- 編號PAA370Mu02
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPA370Mu02-趨化因子 (C-X-C基序)配體7( CXCL7)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 583¥ 1361¥ 1944¥ 4860¥ 19440
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對 CXCL7的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別 CXCL7。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA370Mu01 | 趨化因子 (C-X-C基序)配體7( CXCL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA370Mu02 | 趨化因子 (C-X-C基序)配體7( CXCL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA370Mu01 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體 | WB; IHC. |
| PAA370Mu02 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA370Mu71 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAA370Mu81 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| SEA370Mu | 趨化因子 (C-X-C基序)配體7( CXCL7)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA370Mu | 趨化因子 (C-X-C基序)配體7( CXCL7)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA370Mu01 | 趨化因子 (C-X-C基序)配體7( CXCL7)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Clinical Hemorheology and Microcirculation | Strict heart rate control attenuates prothrombotic state and platelet activity in patients with non-valvular permanent atrial fibrillation.[Pubmed: 2347822] |
| International Journal of Pharma & Bio Sciences | STUDIES ON THE STORAGE OF POOLED PLATELETS IN NON DOP PVC CONTAINERS[Ebscohost: Source] |
| Journal of Affective Disorders | Bioprofiling of platelets in medicated patients with depression.[Pubmed:25451399] |
| Perfusion | Ex vivo simulation of cardiopulmonary bypass with human blood for hemocompatibility testing[PubMed: 26243277] |
| Physiol Behav | Differential changes in platelet reactivity induced by acute physical compared to persistent mental stress[PubMed: 26192713] |
| J Affect Disord | Bioprofiling of platelets in medicated patients with depression[PubMed: 25451399] |
| Turk Kardiyol Dern Ars | Markers of coagulation and fibrinolysis do not detect or predict the presence of left atrial appendage thrombus in patients with atrial fibrillation[Pubmed: 32147650] |
| JOURNAL OF FOOD BIOCHEMISTRY | A novel di‐peptide Met‐Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq‐mediated signaling[Pubmed: 32662128] |
| Membranes (Basel) | Endogenous Nitric Oxide-Releasing Microgel Coating Prevents Clot Formation on Oxygenator Fibers Exposed to In Vitro Blood Flow[Pubmed:35054599] |
| Vaccine | The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats[Pubmed:35183388] |